HSBC Holdings plc (0005): Singapore Life Sale Looks Financially Sensible; Buyback Upside in FY27E

Research evidence excerpt

HSBC Holdings plc (0005): Singapore Life Sale Looks Financially Sensible; Buyback Upside in FY27E

Asia Pacific Equity Research

24 July 2026

Overweight

HSBC Holdings plc (0005) 0005.HK, 5 HK

Price: HK$161.50

Singapore Life Sale Looks Financially Sensible; 23 Jul 2026

Buyback Upside in FY27E Price Target: HK$200.00

PT End Date: 31 Dec 2027

HSBC has announced it will sell 100% of HSBC Life Singapore to Allianz Banks & Financial Services

for US$2.1bn, implying a valuation of c.1.55x HSBC Life Singapore’s AC Katherine Lei

FY25 comprehensive equity. We view this as a sensible move from a (852) 2800-8552

financial perspective, as HSBC Life Singapore contributed only 0.2% of katherine.lei@jpmorgan.com

HSBC Group clean PBT in FY25, while the disposal gain of US$1.8bn J.P. Morgan Securities (Asia Pacific) Limited/

J.P. Morgan Broking (Hong Kong) Limited

upon completion would lift FY27 Group clean PBT by ~4% and increase

Peter Zhang

the CET1 ratio by 15bps, on our estimate, potentially pointing to upside (852) 2800-8557

risk to share buybacks in FY27. From a strategic perspective, as HSBC peter.zhang@jpmorgan.com

will enter into a 15-year bancassurance agreement with Allianz post- J.P. Morgan Securities (Asia Pacific) Limited/

transaction, we believe there should be limited disruption to its Singapore J.P. Morgan Broking (Hong Kong) Limited

banking services. On the other hand, while HSBC Life Singapore is the Lincoln Yu

No.1 insurer for high-net-worth (HNW) clients in Singapore, its overall (852) 2800 8523

lincoln.yu@jpmorgan.com

share of the Singapore life insurance market is only 6%, and we see J.P. Morgan Securities (Asia Pacific) Limited/

potential margin pressure from competition. We reiterate our OW rating J.P. Morgan Broking (Hong Kong) Limited

on HSBC. Haomin Chen